Related Experiment Video
Updated: Nov 30, 2025

16:19
High Throughput Single-cell and Multiple-cell Micro-encapsulation
Published on: June 15, 2012
19.0K
A Low-Cost Open Source Device for Cell Microencapsulation.
Miriam Salles Pereira1,2, Liana Monteiro da Fonseca Cardoso1, Tatiane Barreto da Silva1
1Laboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Materials (Basel, Switzerland)
|November 14, 2020
Summary
Researchers developed a low-cost microencapsulation device for cell therapy, enabling immune protection for cells. This innovation makes advanced cell therapies more accessible, particularly in resource-limited settings.
Area of Science:
- Biomedical Engineering
- Materials Science
- Cell Therapy
Background:
- Microencapsulation is crucial for cell therapy and tissue bioengineering, creating immune-privileged sites.
- Sodium alginate is a common polymer for cell encapsulation due to low toxicity and ease of use.
- Existing commercial encapsulation devices are prohibitively expensive, limiting accessibility.
Purpose of the Study:
- To develop a low-cost microencapsulation device for cell therapy.
- To demonstrate the efficacy of the device in producing viable and functional cell capsules.
- To facilitate accessible cell therapy research and application, especially in low- and middle-income countries.
Main Methods:
- Development of a low-cost device using commercial syringes or 3D printing (approx. $100).
- Utilized sodium alginate for microcapsule production with controllable diameter (around 500 µm).
- Assessed cell viability, functionality, and immune-privileged properties of the microcapsules.
Main Results:
- The developed device successfully produced microcapsules maintaining cell viability and function.
- Capsule porosity confirmed immune protection, preventing host immune cell destruction.
- The low-cost device offers a viable alternative to expensive commercial systems.
Conclusions:
- A cost-effective microencapsulation device has been successfully developed.
- This technology can significantly advance cell therapy research and clinical applications globally.
- The open-source nature of the device promotes accessibility and collaboration in the field.

